Versantis, a private Swiss-based clinical stage biotechnology company focused on addressing the growing unmet medical needs in liver diseases, is to be sold to Genfit. With this acquisition, Genfit intends to expand its product portfolio with a Phase 2 ready programme based on first-in-class scanning liposome technology, a paediatric programme focused on urea cycle disorder […]
Advestra has advised Gnothis on all legal aspects related the two financing rounds of nearly CHF 10 million. Gnothis Holding is a company active in the health sector and has closed this financing rounds this year. Investors include the investment company Nordstjernan and the industrial group Hübner Group. Gnothis, which is based in Cham, is a pioneer in the development […]
Mosanna Therapeutics, a Basel-based biotechnology company, has closed a Seed Financing Round led by Forty51 Ventures. The proceeds will be used for formulation and manufacturing optimization of the molecule MOS118 and for regulatory activities in preparation of the first Phase 1b clinical trial. Mosanna is developing the advanced small molecule MOS118, formerly know as AVE0118, […]
As we announced on February, Promedical, which was acquired earlier this year by a group of investors led by SME Equity Partners and Co-Investor Partners and acting through its parent company, has acquired Lauerz-based Nizell Medical. With this transaction the group further consolidates its position in the Swiss medical consumables market and becomes a leading […]
Swiss biotech company, Engimmune Therapeutics completes its seed financing round raising CHF 15.5 million, co-led by Pureos Bioventures and Novo Holdings with incubation from BaseLaunch. Engimmune Therapeutics is a platform company using cutting-edge technologies to engineer highly potent and specific TCR-based therapies for cancer treatment. Proceeds from the financing will be used to develop novel T-cell […]
Sonova Holding, providers of hearing aid solutions, has completed the placement of CHF 450 million Bonds governed by Swiss law. Application will be made for the Bonds to be listed on the SIX Swiss Exchange. The Bonds will be issued in two tranches, the first tranche with a duration until 2029 and a coupon of […]
KSA Group has taken another important step on the way to the new green building “Dreiklang”, KSA’s new ecological construction project. The KSA Group was able to raise CHF 120 million on the capital market by issuing its first green bond. The offering, which was developed under the leadership of UBS and with the Basellandschaftliche […]
Private equity firm Astrog has entered into a binding agreement with privately owned industrial group International Chemical Investors Group (“ICIG”) whereby Astorg will acquire CordenPharma, a global pharmaceutical CDMO (Contract Development & Manufacturing Organisation) with highly differentiated capabilities in Active Pharmaceutical Ingredients, Excipients, and Drug Products, from ICIG. As part of the transaction, the founders […]
CDR-Life, a Swiss biotechnology company pioneering a new and differentiated class of highly tumor-specific immune-oncology therapeutics, has completed its Series A financing raising USD 76 million. The round was led by Jeito Capital and RA Capital Management, with participation from Omega Funds. Homburger advised CDR-Life in the transaction. The Homburger team was led by partner […]
Groupe Bruxelles Lambert (GBL) acquires a majority stake in Sanoptis, a network of ophthalmology clinics across Germany and Switzerland, from the private equity Telemos Capital. GBL is committing up to EUR 750 million in equity for this transaction with the aim to accelerate the company’s growth in partnership with its management and doctors. In this sense, as part of the transaction, the […]
